Dendrophthoe pentandra is a parasitic plant that has anticancer activity. The leaf of Dendrophthoe pentandra traditionally has been used for anticancer agents. The aim of this study was to investigate whether the combination of Dendrophthoe pentandra leaves extract (DPE) and doxorubicin reduces intracellular calcium concentration [iCa 2+ ] and survivin levels while increasing the number of apoptotic cells in MCF-7 breast cancer cell lines. MCF-7 cells were cultured and divided into six groups: group 1 is a negative control (without DPE nor doxorubicin); group 2 was treated with doxorubicin alone; groups 3-5 were treated with DPE in doses of either 12.5, 25, or 50 µg/ml immediately after doxorubicin treatment, and group 6 was treated with 50 µg/ml of DPE alone. After 24 hours of treatment, we assessed the concentration of iCa
INTRODUCTION
Breast cancer is one of the most common cancers found among women, was diagnosed in an estimated 1.67 million new cases of cancer worldwide in 2012 (Ferlay et al., 2015) . Treatment for breast cancer generally involves surgery and may be augmented by radiation or chemotherapy (Kaabel & Baali., 2015) .
One of the chemotherapy agents prescribed to treat breast cancer is doxorubicin, which is administered with or without another anti-cancer agent depending on the cancer stage and type (Rivankar, 2014) . Despite its anti-cancer activity, doxorubicin has side effects in clinical use, particularly cardiotoxicity and there has been an emergence of resistance (Thorn et al., 2011) . These weaknesses have triggered the search for a treatment method to improve the effect of doxorubicin by developing new therapeutic combinations (Staedler et al., 2011) .
Dendrophthoe pentandra is a parasitic plant, or mistletoe, that grows on mango trees and is traditionally used as a medicinal plant to treat hypertension, measles, cough, and skin infections, and is prescribed as a diuretic and an anticancer agent (Artanti et al., 2012) . The extract of Dendrophthoe pentandra Leaves Extract (DPE) contains secondary metabolites including polyphenols, tannins, flavonoids, steroids, triterpenoids, monoterpenoids, and quinines. Flavonoid is one of the secondary metabolites that has an anticancer effect. Furthermore, one of the flavonoid compounds found in DPE is quercitrin (quercetin-3-rhamnose) (Nurfaat & Indriyati., 2016) . DPE has been shown significantly inhibit proliferation activity in colon cancer in vivo via the p53 independent pathway (Endharti et al., 2016) . The activities of DPE in inducing apoptosis in human breast (T47D) and leukemia (K562R) cell lines have also been investigated (Widowati et al., 2013; Zamani et al., 2016) . In addition, the combination of DPE and doxorubicin has also been shown to enhance the antitumor effect of doxorubicin in liver and breast cancer cells Staedler et al., 2011) .
In cancer cells, there are imbalances in the apoptosis process as well as uncontrolled cell proliferation (Dubois et al., 2013) . Apoptosis can be induced by various conditions, such as the presence of disruption of intracellular calcium homeostasis (Harr & Distelhorst., 2010) . Calcium-dependent apoptosis involves two factors: sustained increases in intracellular calcium and a prolonged reduction of calcium in the endoplasmic reticulum (ER) (Dubois et al., 2013) . Apoptosis can be inhibited by anti-apoptosis proteins such as survivin, which is overexpressed in a majority of breast cancers (Jha et al., 2012; Jaiswal et al., 2015) . The antiapoptotic activity of survivin is blocked by apoptosis inducer such as p53 protein (Jaiswal et al. 2015) .
The efficacy of the combination of DPE and doxorubicin as an anti-cancer treatment is unclear. In this study, we investigated the combined effects of doxorubicin and DPE on survivin levels, intracellular calcium concentration, and the number of apoptotic cells in MCF-7 breast cancer cells.
MATERIALS AND METHODS

Plant material and extraction
Dendrophthoe pentandra fresh leaves were collected from Probolinggo, East-Java, Indonesia and the identification of the plants were done at the Department of Biology, University of Brawijaya (specimen No. 0170/Taxonomy Identification/03/2015). The leaves of Dendrophthoe pentandra were extracted according to the protocol described by Endharti et al. (2016) .
Cell cultures
MCF-7 cell line was cultured in Roswell Park Memorial Institute 1640 (RPMI 1640) (Gibco, USA) medium supplemented with 10% Fetal Bovine Serum (FBS) (Atlas Biologicals, Fort Collins, Co, USA), 100 U/ml streptomycin and 100 U/ml penicillin (Gibco, USA). Cells were kept in an incubator in a humidified atmosphere of 5% CO 2 at 37°C.
Measurement of intracellular calcium [iCa2+]
Measurement of [iCa 2+ ] accumulation was labeled by Fluo 3-AM (Bioscience, USA), a fluorescent probe, was applied to determine intracellular calcium, Briefly, MCF-7 cells were plated in 24 well at density 1 × 105 cells per well. After 24 hours of incubation, the culture medium was replaced with medium containing 5 µg/ml doxorubicin (Sigma, USA) with or without DPE and then incubated for 24 hours. Cells were rinsed with PBS followed by dilution in PBS + Ca 2+ + Mg 2+ containing 1 mM sodium pyruvate and EGTA. Fluo3-AM was added to obtain a final concentration of 5 μM and then incubated in the darkroom for 30 min at room temperature. The sample was measured by flow cytometer. Intracellular calcium fluorescence was analyzed using Cell Quest ProTM software (BD FACS Calibur) and measured on FL-1 (voltage 600).
Flow cytometry analysis for survivin
Percentage of survivin was determined quantitatively by flow cytometry using the survivin-antibody (D-8) sc-17779 conjugated with FITC (Santa Cruz Biotechnology, Germany) following the manufacturer's protocol. Briefly, MCF-7 cells were plated at a density 1 × 10 5 cells per well and incubated overnight. The cells were treated with doxorubicin 5 µg alone or with DPE (12.5, 25 and 50 µg/ml) for 24 hours followed by trypsinization. Cells were harvested and the pellets were re-suspended in Fixation buffer (Biolegend, San Diego, California, USA) and incubated at 4°C for 30 min. The pellets were incubated with survivin antibody for 20 min. The samples were immediately analyzed by Cell Quest ProTM software (BD FACS Calibur, Becton Dichinson, San Jose, USA).
Apoptosis analysis
Apoptosis cells were determined quantitatively by flow cytometry using the annexin V-conjugated FITC (eBioscience) following the manufacturer's protocol. Briefly, MCF-7 cells were cultured in a 24-well plate at a density of 2 × 10 5 /well. The cells were treated with doxorubicin 5 µg alone or with DPE (12.5, 25 and 50 µg/ml) for 24 hours followed by trypsinization. Cells were resuspended in 2.5 μg/ml Annexin-V-FITC and 50 μg/ml propidium iodide (PI) (Biolegend) were added to the cell suspension and incubated for 5 min at room temperature (25°C) in the dark. The apoptosis level was measured by quantifying the population of Annexin V-FITC-positive cells. Flow cytometry data were plotted and analyzed by Cell-Quest software (FACS Calibur TM; Becton-Dickinson).
Statistical analysis
The results were analyzed by the one-way ANOVA test, followed by Post Hoc Tukey test. Data were described as a mean ± standard deviation. Statistical significance of a difference between groups, with P < 0.05 being considered significant. Statistical analysis was performed with SPSS software version 11.0 (SPSS Inc., Chicago, IL, USA).
RESULTS AND DISCUSSION
Results
Doxorubicin combined with DPE decreased Intracellular Calcium.
The [iCa 2+ ] alteration after treatment with a combination of doxorubicin and DPE was observed by flow cytometry (Figure 1) . A decline in [iCa 2+ ] was observed as demonstrated by decreasing of fluorescence intensity. The results showed that a combination of doxorubicin and DPE decreased intracellular calcium ( Figure 1A &1B ). As shown in figure 2B , the doxorubicin treatment combined with DPE at doses 25 µg/ml and 50 µg/ml reduced intracellular calcium concentration significantly at 17% (P < 0.05) and 14% (P < 0.01), respectively.
Co-treatment doxorubicin and DPE reduced the level of survivin
The results of survivin levels measurement by flow cytometry were shown in Figure 2 . Figure 2B exhibit doxorubicin treatment combined with DPE at doses of 25 µg/ml and 50 µg/ml reduced survivin levels significantly at 27% and 19%, respectively (P < 0.01). 
The combination of doxorubicin and DPE synergistically induced apoptosis
The MCF-7 cell culture was exposed to doxorubicin at a dose of 5 µg/ml alone or combined with DPE at doses of 12.5 µg/ml, 25 µg/ml, 50 µg/ml. Annexin V conjugated fluorochrome-FITC and propidium iodide (PI) (Sigma, Kawasaki, Japan) staining was performed to investigate whether the combination of doxorubicin and DPE induced cell death through apoptosis. The results of flow cytometry showed the percentage of apoptotic cells represented in dot plot ( Figure 3A) . Doses of 12.5-50 µg/mL DPE enhanced apoptosis of doxorubicin against MCF-7 cells in a dose-dependent manner. When DPE and doxorubicin were used in combination, the number of apoptosis cells was significantly increased compared with doxorubicin treatment alone ( Figure  3B) ; P < 0.05). 
Discussion
Various studies have been conducted with the aim of improving the efficacy of existing chemotherapy drugs. One method developed is combining chemotherapy agents either with different chemotherapy agents or with other substances such as herbs. In this study, we investigated the combination effect of doxorubicin and DPE on intracellular calcium concentrations, survivin levels and apoptosis in MCF-7 breast cancer cells.
The results of our study showed that treatment of MCF-7 cells with the combination of doxorubicin and DPE declined the concentration of intracellular calcium. We assume that the mechanisms of this phenomenon because of the treatment of doxorubicin and DPE able to decrease Bcl-2 protein. The decreasing of Bcl-2 protein induces calcium release from the endoplasmic reticulum. The argument corresponds to Tacar et al. (2012) reported that doxorubicin stimulates an increase of p53, which blocks the Bcl-2 protein. Moreover, DPE directly decreases the Bcl-2 protein (Duo et al., 2012; Mekahli et al., 2011) . Furthermore, DPE has been shown anti-estrogenic effects on breast cancer cell lines (MCF-7) (Yigitaslan et al., 2016) , inhibition of estrogen receptor by DPE will reduce Orai3 expression that causes decreasing calcium influx (Faouzi et al., 2010) . Here are some of the mechanisms suggested to explore in the future research.
In this experiment, the number of apoptotic cells in MCF-7 cell lines was further assessed by flow cytometry. Our results demonstrated that the combination treatment of doxorubicin with or without DPE was able to induce apoptosis. This data prove that the combination of doxorubicin and DPE decreased the survival rate of MCF-7 breast cancer cells. Our results supported by Sharifi et al. (2015) and Pilco-ferreto & Calaf. (2016) which showed that doxorubicin induces apoptosis in MCF-7 and MDA-MB-231 Pilco-ferreto & Calaf. (2016) cell lines, DPE was able to increase apoptosis in a human chronic myeloid leukemia cell line (K562) (Zamani et al., 2016) .
According to our results, the combination of DPE and doxorubicin directly involve in the decreasing of survivin levels, we supposed that doxorubicin activates p53 lead to suppressing on survivin levels. Whereas DPE decrease surviving level in MCF-7 cells line. Our results are in line with previous report indicating that doxorubicin inhibits topoisomerase 2 enzymes, causing DNA damage (Deng et al., 2013; Thorn et al., 2011) and increase the activation of p53-induced apoptosis pathway (Farfariello et al., 2015) lead to suppress on the survivin level (Tyner et al., 2012; Garg et al., 2016) .
In addition, the mechanism of action of. The disruption of calcium homeostasis may induce apoptosis (Harr et al., 2010) while survivin acts as an apoptotic inhibitor (Deng et al., 2013) . These findings showed a decrease in intracellular calcium concentration and survivin levels while apoptosis rose. This study suggests that the apoptotic effects of co-treatment of doxorubicin and DPE in MCF-7 cells involve intracellular calcium and survivin.
CONCLUSIONS
Our results demonstrate that DPE effectively promotes the anti-cancer effects of doxorubicin in MCF-7 cells. The apoptotic effects of the combination of doxorubicin and DPE is mediated by reduction of intracellular calcium and survivin levels. Our results indicate that the combination of doxorubicin and DPE may be beneficial as a potential anti-cancer drug in the future.
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